Antonio Speziale joins Enthera with drug development and commercialization experience from roles at Galapagos, Shire, Novartis, Genzyme and Wyeth Milan, Italy, 4 October 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, has appointed Antonio Speziale as Chief Medical Officer. […]
https://www.entherapharmaceuticals.com/wp-content/uploads/2019/10/logo-300x85.png00heartenhttps://www.entherapharmaceuticals.com/wp-content/uploads/2019/10/logo-300x85.pnghearten2021-10-04 09:05:202021-10-06 10:32:16Enthera Pharmaceuticals appoints Antonio Speziale as Chief Medical Officer
The OpenZone drug discovery unit will be used to support Enthera’s new discovery program and accelerate its mission to identify new treatments for intractable autoimmune diseases Milan, Italy, 7 July 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, today […]
https://www.entherapharmaceuticals.com/wp-content/uploads/2019/10/logo-300x85.png00heartenhttps://www.entherapharmaceuticals.com/wp-content/uploads/2019/10/logo-300x85.pnghearten2021-07-06 16:38:172021-07-06 16:40:54Enthera Pharmaceuticals opens early drug discovery unit at OpenZone life sciences campus to expand autoimmune disease research
Milan, Italy, 1 April 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing novel disease-modifying biologics that re-establish stem cell capabilities to treat specific autoimmune diseases, today announces the appointment of Claudia Nardini as Vice President of Research and Development to support the Company’s manufacturing and regulatory divisions. Claudia has 25 years of experience in […]
https://www.entherapharmaceuticals.com/wp-content/uploads/2019/10/logo-300x85.png00heartenhttps://www.entherapharmaceuticals.com/wp-content/uploads/2019/10/logo-300x85.pnghearten2021-04-01 09:00:432021-07-06 13:39:26Enthera Pharmaceuticals Appoints Claudia Nardini as Vice President of Research and Development
Enthera Pharmaceuticals appoints Antonio Speziale as Chief Medical Officer
/in Press ReleasesAntonio Speziale joins Enthera with drug development and commercialization experience from roles at Galapagos, Shire, Novartis, Genzyme and Wyeth Milan, Italy, 4 October 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, has appointed Antonio Speziale as Chief Medical Officer. […]
Enthera Pharmaceuticals opens early drug discovery unit at OpenZone life sciences campus to expand autoimmune disease research
/in Press ReleasesThe OpenZone drug discovery unit will be used to support Enthera’s new discovery program and accelerate its mission to identify new treatments for intractable autoimmune diseases Milan, Italy, 7 July 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, today […]
Enthera Pharmaceuticals Appoints Claudia Nardini as Vice President of Research and Development
/in Press ReleasesMilan, Italy, 1 April 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing novel disease-modifying biologics that re-establish stem cell capabilities to treat specific autoimmune diseases, today announces the appointment of Claudia Nardini as Vice President of Research and Development to support the Company’s manufacturing and regulatory divisions. Claudia has 25 years of experience in […]